000 04163nam a22003975i 4500
999 _c393388
_d393388
_x1
001 393388
003 ES-MaUEC
005 20240314174351.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 130402s2013 xxu| fo |||| 0|eng d
020 _a9781627033398
024 7 _a10.1007/978-1-62703-339-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQP93.5
_b2013 EB
245 0 0 _aHaemostasis
_b: Methods and Protocols
_cedited by Paul Monagle
250 _a1st edition 2013
264 1 _aTotowa, NJ
_bHumana Press
_c2013
300 _a1 recurso en línea (XIII, 431 páginas)
_b37 ilustraciones, 19 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v992
505 0 _aThe Coagulation System in Humans -- Platelet Physiology -- The Role of the Blood Vessel Wall -- Specimen Requirements for the Haemostasis Laboratory -- Principles of Haemostasis Tests -- Reference Ranges of Coagulation Tests -- Lupus Anticoagulant Testing -- Activated Partial Thromboplastin Time (APTT) -- Prothrombin Time (PT) and International Normalised Ratio (INR) -- Thrombin Clotting Time (TCT) -- Thrombin Generation -- Activated Clotting Time (ACT) -- Factor XII Assays -- Fibrinogen -- Platelet Counting -- Platelet Morphology Analysis -- Light Transmission Aggregometry -- Platelet Flow Cytometry -- Anti-factor Xa assay (anti-Xa) -- Reptilase Time (RT) -- Protamine Titration -- Laboratory Methods for the Assay if Tissue Factor Pathway Inhibitor (TFPI) in Human Plasma -- Heparin Induced Thrombocytopenia (HIT) -- Nijmegen-Bethesda Assay to Measure Factor VIII Inhibitors -- Kaolin Clotting Time -- The Dilute Russell Viper Venom Time (DRVVT) -- Platelet Neutralisation Test -- Antithrombin -- Protein C -- Protein S -- Testing for Hyperhomocysteinemia in Subjects with a History of  Thromboembolic Events Using HPLC Technique -- Anticardiolipin Antibody and Anti-Beta 2 Glycoprotetin I Assays -- Testing for Apolipoprotein (a) Phenotype Using Isoelectric Focusing and  Immunoblotting Technique -- D-Dimer and Fibrinogen/Fibrin Degradation Products.
520 _aThe haemostatic system is one the most important physiological systems for maintaining health and well being, and thus the investigation of the haemostatic system remains a research priority. Disturbances of the haemostatic system in the broader sense, such as heart disease and strokes, arguably constitute the single greatest contribution to non-infectious mortality in the world today. Therefore, understanding the laboratory methods to assess the haemostatic system is vital for the practice of complex clinical medicine. In Haemostasis: Methods and Protocols, experts in the field address the major components of the haemostatic system, general principles of haemostatic testing, and techniques used to assess various aspects of the haemostatic system, grouped according to their functional indications. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Haemostasis: Methods and Protocols provides an ideal guide to scientists of all backgrounds and serves an urgent need for further research to develop superior methods of assessing the haemostatic system in humans.
988 _aSpringer_Protocols_2013
650 7 _2embne
_9550450
_aHemostasia
776 0 8 _iPrinted edition:
_z9781627033381
776 0 8 _iPrinted edition:
_z9781627033404
776 0 8 _iPrinted edition:
_z9781493961023
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-62703-339-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2024
_dz
_ean
_zSI